Skip to main content

Table 1 Demographics

From: Augmentation index and aortic stiffness in bicuspid aortic valve patients with non-dilated proximal aortas

Descriptives

BAV

TAV

p-value

Age

46.5 ± 11.6

46.3 ± 15.1

0.97

Males (n, %)

6 (60%)

10 (77%)

0.40

Height (in)

66.0 ± 4.2

70.0 ± 3.5

0.02*

Weight (lbs)

188.9 ± 52.9

180.3 ± 48.9

0.69

Body mass index

30.1 ± 6.8

25.8 ± 5.8

0.10

Body surface area (m3)

1.98 ± 0.32

1.99 ± 0.32

0.93

Systolic blood pressure (mmHg)

118.3 ± 14.4

120.7 ± 13.4

0.69

Diastolic blood pressure (mmHg)

71.7 ± 11.6

70.2 ± 7.9

0.72

Pulse pressure (mmHg)

46.6 ± 11.4

50.6 ± 13.0

0.46

Mean arterial pressure (mmHg)

87.2 ± 11.4

87.0 ± 7.9

0.97

Heart rate (bpm)

64.1 ± 6.4

62.4 ± 12.6

0.70

Ejection fraction (%)

59.0 ± 3.1

58.5 ± 3.2

0.67

Aortic root diameter (cm)

3.14 ± 0.52

3.06 ± 0.34

0.75

Aortic root index (cm/m3)

1.59 ± 0.18

1.56 ± 0.26

0.69

Ascending aortic diameter (cm)

3.24 ± 0.46

2.87 ± 0.46

0.07

Ascending aortic index (cm/m3)

1.67 ± 0.35

1.45 ± 0.20

0.40

Aortic stenosis: mild (n, %)

5 (50%)

None

-

Peak aortic velocity (cm/sec)

217.5 ± 43.3

174.4 ± 45.8

0.001*

Peak wall shear rate (sec-1)

285.1 ± 18.9

180.1 ± 20.7

0.001*

Aortic insufficiency:

3 (30%)

2 (15%)

0.02*

Trace (n, %)

4 (40%)

1 (7.7%)

Mild (n, %)

Risk factors (n)

Hypertension

5 (50%)

5 (38%)

0.60

Hypercholesterolemia

4 (40%)

6 (46%)

0.85

Coronary artery disease

1 (10%)

2 (15%)

0.20

Tobacco use

1 (10%)

3 (23%)

0.72

Diabetes mellitus

1 (10%)

1 (7.7%)

0.44

Medications (n)

ASA

4 (40%)

2 (15%)

0.72

Anti-coagulants

1 (10%)

2 (15%)

0.20

Beta-blockers

5 (50%)

3 (23%)

0.72

ACE inhibitors/ARB

3 (30%)

3 (23%)

0.42

Statins

3 (30%)

2 (15%)

0.85

  1. Shown are the mean ± standard deviation of the mean.